Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac
Molecules · 2024
DOI: 10.3390/molecules29245867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Eric Asare und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, US…. Hauptthemen laut MEDLINE: Diclofenac, Glucuronides, Microsomes, Liver, Species Specificity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas, National Institute of Minority Health and Health Disparity, NIMHD NIH HHS.
Abstract (Originalsprache)
Background
The aim of this study is to determine the impact of species and tissue differences on the glucuronidation of diclofenac in vitro.
Method
Microsomes from different species (rat, monkey, mouse, dog, and human) and rat and human tissues (liver, intestine, and kidney) were used to assess the rate of glucuronidation reaction of diclofenac. The metabolites were quantified using ultra high-performance liquid chromatography (UHPLC) and fitted into a Michaelis–Menten model to determine the metabolic kinetic parameters.
Results
The results showed higher rates of metabolism in the liver as compared to that of the intestine and kidney by both human and rat tissues microsomes. There were also differences in the rate of metabolism in the liver across the tested species, with mouse liver microsome having the highest maximum reaction rate (Vmax) at 7.22 nmol/min/mg followed by human liver microsome at 6.66 ± 0.33 nmol/min/mg, dog liver microsome at 5.05 ± 0.42 nmol/min/mg, monkey liver microsome at 3.88 ± 0.15 nmol/min/mg, and rat liver microsome at 0.83 ± 0.04 nmol/min/mg.
Conclusions
This study demonstrated that the liver is the major organ for the glucuronidation of diclofenac. In addition, glucuronidation of diclofenac was different across the tested species; therefore, the influence of species should be taken into consideration in the pharmacological, pharmaceutical, and toxicological study of diclofenac.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Science, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, TX 77004, USA.
ORCID-Profile: Eric Asare, Shalom Emmanuel, Ting Du, Huan Xie, Dong Liang, Song Gao
Förderung
- Cancer Prevention and Research Institute of Texas
- National Institute of Minority Health and Health Disparity
- NIMHD NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- GCC Center for Comprehensive PK/PD and Formulation (CCPF)
Zitieren
APA
Asare, E., Emmanuel, S., Du, T., Xie, H., Liang, D., & Gao, S. (2024). Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac. Molecules. https://doi.org/10.3390/molecules29245867
Vancouver
Asare E, Emmanuel S, Du T, Xie H, Liang D, Gao S. Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac. Molecules. 2024. doi:10.3390/molecules29245867
BibTeX
@article{Asare2024,
author = {Asare, Eric and Emmanuel, Shalom and Du, Ting and Xie, Huan and Liang, Dong and Gao, Song},
title = {Impact of Species and Tissue Differences on In Vitro Glucuronidation of Diclofenac},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29245867}
}
EUVIMED